ipamorelin clinical trials safety adverse effects hormonal inquiry cjc-1295 ipamorelin anti-aging benefits studies Sublingual CJC-1295 ipamorelin clinical trials safety adverse

Medically reviewed by Lauren Okafor | MD , The Frank H Netter MD School of Medicine, Loyola University Medical Center on March 16th, 2026

Very low or high blood levels of homocysteine can indicate a B12, folate, and/or B6 deficiency (21)

Sermorelin binds to the same GHRH receptor as CJC-1295 but has a very short half-life (10 to 20 minutes), limiting its GH pulse duration

Co-administration of bisphosphonates has been shown to retard the rate of bone loss in corticosteroid-treated males and post-menopausal females, and these agents are recommended in the prevention and treatment of corticosteroid-induced osteoporosis